Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04706000
Status:
COMPLETED
Last Update Posted:
2023-12-06
First Post:
2021-01-08
Brief Title:
Autophagy Markers in Endometrial Polyps
Sponsor:
Muğla Sıtkı Koçman University
Organization:
Muğla Sıtkı Koçman University
Study Overview
Official Title:
Investigation of Autophagy Markers in Endometrial Polyps
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this research is to evaluate autophagy markers in patients with endometrial polyps
Detailed Description:
Endometrial polyp are benign formations that are frequently encountered in gynecology practice and have malignant potential It may be asymptomatic in the clinic or may present with abnormal uterine bleeding Although its pathophysiology has not been clearly revealed there are many studies in the literature about it However the autophagy pathway emerges as a subject that has never been evaluated In this study the investigators would like to prospectively evaluate Beclin 1 LC3A B and p62 markers in the autophagy pathway in endometrial polyp tissue samples by immunohistochemistry and reveal their importance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None